文摘
Blocking reagent is of vital importance for an immunosensor because it ensures the antifouling of the sensing interface and thus selective determination of the target. This Letter investigates a small inactive peptide, oxidized glutathione (GSSG), to replace the commonly used bovine serum albumin (BSA) as blocking reagent for immunosensor fabrication to lower the detection limit of electrochemical immunosensors. The EGF (epidermal growth factor) detection as an example is used here to compare the blocking effects from GSSG and BSA, respectively. The relatively big size of BSA sterically hinders EGF and antibody functionalized silver nanoparticles (Ab-AgNPs) binding. By comparison, GSSG cannot hinder EGF and Ab-AgNPs binding since it is much smaller than EGF, verified by scanning electron microscopy (SEM) results. The established GSSG blocking-based immunosensor for EGF reaches a very low detection limit of 0.01 pM, exhibits wide linearity range between 0.1 pM and 0.1 渭M and is more sensitive than the BSA blocking strategy. The proposed GSSG-blocking strategy in the immunoassay paves an attractive platform for other biomolecules to reach a lower detection limit.